News und Analysen
![Analysts Are Recommending Symbiotic In July, High Potential?: https://www.marketbeat.com/logos/articles/med_20230714054831_analysts-are-recommending-symbiotic-in-july-high-p.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOVZPYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--6e33974c9e0eb78fadadd35b4fc4bf58c4a35768/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230714054831_analysts-are-recommending-symbiotic-in-july-high-p.jpg?locale=de)
Analysts Are Recommending Symbiotic In July, High Potential?
Every market turn, such as the one investors encounter today, brings to light a set of favorite industries with their own set of perceived 'winning' stocks. The larger the underlying pivot, the
![Will Cintas Scale a New High in 2023?: https://www.marketbeat.com/logos/articles/med_20230713120237_will-cintas-scale-a-new-high-in-2023.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOXBPYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--db96a10d010fa9379fd6a16246d883dc695a6359/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230713120237_will-cintas-scale-a-new-high-in-2023.jpg?locale=de)
Will Cintas Scale a New High in 2023?
Despite its already-high valuation, Cintas (NASDAQ: CTAS) can scale new highs in 2023. Its FQ4 results and guidance confirm the business trajectory's growing and widening margin.
As highly
![Eilt: Hautkrebs-Studie mit sensationellen Ergebnissen - Massives Kaufsignal. Neuer 204% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2023/71337/AC-140723.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM1ZPYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--63a6a13be77b3f06723db5855005e6b1684040e3/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AC-140723.001.png?locale=de)
Eilt: Hautkrebs-Studie mit sensationellen Ergebnissen - Massives Kaufsignal. Neuer 204% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Hautkrebs-Studie mit sensationellen Ergebnissen - Massives Kaufsignal. 204% Biotech Aktientip nach 15.973% mit BioNTech
14.07.23 08:02
London (www.aktiencheck.de , Anzeige)
![3 Reasons Why Rivian Can Continue To Surge Higher: https://www.marketbeat.com/logos/articles/med_20230713073013_rivn-2.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNzlOYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--1eb7376d5ba8d891a56b11574861d166176a0e4a/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230713073013_rivn-2.jpg?locale=de)
3 Reasons Why Rivian Can Continue To Surge Higher
Just over a week ago, shares of Rivian Automotive (NASDAQ: RIVN) were in the negative year-to-date. When I first wrote about Rivian precisely one week ago, the stock was up just 6.13% YTD. Today
![Despite Breaking Higher, Analysts Remain Cautious HP Inc.: https://www.marketbeat.com/logos/articles/med_20230713073337_despite-breaking-higher-analysts-remain-cautious-h.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNHROYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--ae63509a6b2687d7c1ca2dc4c2a0ffe8a38d59c0/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230713073337_despite-breaking-higher-analysts-remain-cautious-h.jpg?locale=de)
Despite Breaking Higher, Analysts Remain Cautious HP Inc.
The computer and office equipment giant HP Inc. (NYSE: HPQ) has been trading steadily higher this year, with the stock up over 22%. Shares of HPQ recently broke above a critical level of
![PepsiCo Can Soar To New Highs In The 2nd Half: https://www.marketbeat.com/logos/articles/med_20230713071024_chart-pep-7132023.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNGhOYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--b0ef0aa3634219fb6c122b72f65ed7553ce56318/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230713071024_chart-pep-7132023.png?locale=de)
PepsiCo Can Soar To New Highs In The 2nd Half
PepsiCo (NASDAQ: PEP) has been leading the beverage and consumer staples market for years, and the company is unlikely to lose its position. The Q2 results prove the pep+ strategy is working and
![Motorola Approaches Buy Point As Analysts Boost Price Targets: https://www.marketbeat.com/logos/articles/med_20230713072026_motorola-approaches-buy-point-as-analysts-boost-pr.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNDFOYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--0ac89684d1ee88104038a822b5abad466bb14b89/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230713072026_motorola-approaches-buy-point-as-analysts-boost-pr.jpg?locale=de)
Motorola Approaches Buy Point As Analysts Boost Price Targets
S&P 500 component Motorola Solutions Inc. (NYSE: MSI) is within 1% of a buy point, getting a boost on July 12 along with the broader market.
A look at the Motorola Solutions chart shows the
![High Rollers Loading Up On DraftKings As Upgrades Roll In: https://www.marketbeat.com/logos/articles/med_20230713070622_high-rollers-loading-up-on-draftkings-as-upgrades.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNGxOYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--d64dbf60e54c9af4233c3d875188f93ee9dae08b/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230713070622_high-rollers-loading-up-on-draftkings-as-upgrades.jpg?locale=de)
High Rollers Loading Up On DraftKings As Upgrades Roll In
DraftKings Inc. (NASDAQ: DKNG) has been a good bet lately, with the stock showing gains in every month so far in 2023.
Shares have been registering strong price gains since July 7, when the stock
![3 Hotel Stocks Earning Five Star Ratings From Markets In July: https://www.marketbeat.com/logos/articles/med_20230712151429_3-hotel-stocks-earning-five-star-ratings-from-mark.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBelZOYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--dd93f0dea7443d8ed7d5128326cd5a77780f1752/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230712151429_3-hotel-stocks-earning-five-star-ratings-from-mark.jpg?locale=de)
3 Hotel Stocks Earning Five Star Ratings From Markets In July
Markets can have their pick-and-choose cycles for their favored sectors in the economy. The hotel and accommodation spaces are among the few sectors pushing the U.S. economy forward, despite FED
![ARKK: The Pros and Cons Of Buying Into Cathie's Best-Known ETF: https://www.marketbeat.com/logos/articles/med_20230712145525_arkk-the-pros-and-cons-of-buying-into-cathies-best.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBek5OYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--da0f4f326f273c7c0de68e712b49b885eace941b/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230712145525_arkk-the-pros-and-cons-of-buying-into-cathies-best.jpg?locale=de)
ARKK: The Pros and Cons Of Buying Into Cathie's Best-Known ETF
There was a time when Cathie Woods and her flagship ARKK Innovation ETF (NYSEARCA: ARKK) could do no wrong. Helped in a large way by rock-bottom interest rates and arguably the greatest sense of
![Netflix Can Soar Higher In The 2nd Half: https://www.marketbeat.com/logos/articles/med_20230712104748_copy-1-of-chart-nflx-7122023.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBelpOYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--4c55420b733cfe3819ac79feb86161a14346af2d/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230712104748_copy-1-of-chart-nflx-7122023.png?locale=de)
Netflix Can Soar Higher In The 2nd Half
Netflix (NASDAQ: NFLX) made some big changes over the last year, but the signs are good that those changes are working for the better. The combination of password-sharing initiatives and
![3 Biotech Stocks to Buy for Long-Term Gains: https://www.marketbeat.com/logos/articles/med_20230712120806_3-biotech-stocks-to-buy-for-long-term-gains.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBemROYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--5c04e98cd4261cd61ec3e977f2402dff8e942c65/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230712120806_3-biotech-stocks-to-buy-for-long-term-gains.jpg?locale=de)
3 Biotech Stocks to Buy for Long-Term Gains
Suppose you’re looking for a sector that will benefit from an end to the Federal Reserve’s interest rate hiking campaign. In that case, you may look at biotech stocks, a sector filled with
![Sensationeller Erfolg im Kampf gegen Hautkrebs - Massives Kaufsignal. Neuer 206% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB). Jetzt 206% mit Biotech Hot Stock: https://www.irw-press.at/prcom/images/messages/2023/71323/AC-130723-2.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOVpNYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--de98086908f29e9baed0751938cefe6b077f7f63/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AC-130723-2.001.png?locale=de)
Sensationeller Erfolg im Kampf gegen Hautkrebs - Massives Kaufsignal. Neuer 206% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB). Jetzt 206% mit Biotech Hot Stock
Sensationeller Erfolg im Kampf gegen Hautkrebs - Massives Kaufsignal. 206% Biotech Aktientip nach 134.452% mit Biogen
13.07.23 08:18
London (www.aktiencheck.de, Anzeige)
![Alibaba Just Flashed Green, Very Green: https://www.marketbeat.com/logos/articles/med_20230712095334_alibaba-just-flashed-green-very-green.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeXhNYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--c0e6085aed6fea26bee28b6fc13c910372686817/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230712095334_alibaba-just-flashed-green-very-green.jpg?locale=de)
Alibaba Just Flashed Green, Very Green
After trading sideways in a tight range for more than a year, the stars are finally aligning once more for Alibaba Group Holding Ltd (NYSE: BABA) stock. Shares of the Chinese e-commerce and cloud
![This Small Cap Stock Surged Over 100%: https://www.marketbeat.com/logos/articles/med_20230712094933_this-small-cap-stock-surged-over-100.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeTFNYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--d0f064f22b357977baeea0245b9bab42886dffc9/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230712094933_this-small-cap-stock-surged-over-100.jpg?locale=de)
This Small Cap Stock Surged Over 100%
Arguably the most impressive mover yesterday was a stock you have probably never heard of. Shares of Eloxx Pharmaceuticals (NASDAQ: ELOX) rocketed almost 100% yesterday after receiving an
![Activision Surges 10% As Judge OK's Microsoft Acquisition Deal: https://www.marketbeat.com/logos/articles/med_20230712072851_activision-surges-10-as-judge-oks-microsoft-acquis.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBK0JMYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--7624041e7a2b3900fc27b6663c72ab006385e65f/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230712072851_activision-surges-10-as-judge-oks-microsoft-acquis.jpg?locale=de)
Activision Surges 10% As Judge OK's Microsoft Acquisition Deal
Activision Blizzard Inc. (NASDAQ: ATVI) shares rose to the call of duty on July 11, advancing 10.02% in heavy trading volume as a federal judge gave the OK for Microsoft Corp. (NASDAQ: MSFT) to
![Erstklassige Studienergebnisse im Kampf gegen Hautkrebs - Massives Kaufsignal. Neuer 208% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2023/71305/Aktiencheck_Vidac_120723.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBenRMYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--5b3f64bfef07fa8bd92ce1bf962296d13aace5ef/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Aktiencheck_Vidac_120723.001.png?locale=de)
Erstklassige Studienergebnisse im Kampf gegen Hautkrebs - Massives Kaufsignal. Neuer 208% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Erstkl. Studienergebnisse im Kampf gegen Hautkrebs - Massives Kaufsignal. 208% Biotech Hot Stock nach 31.205% mit Amgen
12.07.23 08:02
London (www.aktiencheck.de, Anzeige)
![Grid Dynamics begrüßt Valery Zelixon, eine bewährte Führungskraft für die Umsatzentwicklung, als Senior Vice President of Sales: https://www.irw-press.at/prcom/images/messages/2023/71295/GridDynamics_110723_DEPRcom.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBejFLYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--842ab289f225f75dcbbc559171224657a56dc7ad/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/GridDynamics_110723_DEPRcom.001.png?locale=de)
Grid Dynamics begrüßt Valery Zelixon, eine bewährte Führungskraft für die Umsatzentwicklung, als Senior Vice President of Sales
Wichtigste Eckdaten:
- Valery Zelixon wechselt als Senior Vice President of Sales zu Grid Dynamics. Unter seiner Führung wird Grid Dynamics seinen Fokus auf Vertrieb und neue
![Grid Dynamics Welcomes Valery Zelixon, a Proven Revenue Catalyst, as Senior Vice President of Sales: https://www.irw-press.at/prcom/images/messages/2023/71295/GridDynamics_110723_ENPRcom.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMEJLYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--9f3b2fc182871cbf82c0cf0fcac527213466a923/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/GridDynamics_110723_ENPRcom.001.png?locale=de)
Grid Dynamics Welcomes Valery Zelixon, a Proven Revenue Catalyst, as Senior Vice President of Sales
Key Takeaways:
- Valery Zelixon joins Grid Dynamics as Senior Vice President of Sales, and under his leadership, Grid Dynamics will enhance its focus on sales and new growth
![Pullback Creates an Opportunity for ‘The Amazon of Latin America': https://www.marketbeat.com/logos/articles/med_20230711072655_pullback-creates-an-opportunity-for-the-amazon-of.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMGRLYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--2b2b17e1417406d29d080c8bdd6798ffb28d452f/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230711072655_pullback-creates-an-opportunity-for-the-amazon-of.jpg?locale=de)
Pullback Creates an Opportunity for ‘The Amazon of Latin America'
Latin American e-commerce leader MercadoLibre, Inc. (NASDAQ:MELI) surpassed consensus earnings estimates in each of the last five quarters. This includes a resounding 42% first quarter beat that
![Could CAVA Be The Next Chipotle? Here's How Close It Gets: https://www.marketbeat.com/logos/articles/med_20230711072351_could-cava-be-the-next-chipotle-heres-how-close-it.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMGhLYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--390836405217f45c7315e6c159e5b8906d4cdb7b/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230711072351_could-cava-be-the-next-chipotle-heres-how-close-it.jpg?locale=de)
Could CAVA Be The Next Chipotle? Here's How Close It Gets
The United States IPO (Initial Public Offering) market had been on a dry spell during the past few months due to more challenging than average financing rates and hurdles, aided by a FED acting to
![This Autonomous Vehicle Stock Doubled in June and May Do It Again: https://www.marketbeat.com/logos/articles/med_20230711071116_this-autonomous-vehicle-stock-doubled-in-june-and.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMFpLYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--9763764aca38e191fa9ca0909ada31268649eab8/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230711071116_this-autonomous-vehicle-stock-doubled-in-june-and.jpg?locale=de)
This Autonomous Vehicle Stock Doubled in June and May Do It Again
Like the classic Willie Nelson song, self-driving technology company Aurora Innovation, Inc. (NASDAQ: AUR) is “on the road again.”
The former SPAC winner turned penny stock loser is up 131% this
![Massive Upside Forecasted In Alta Equipment Group: https://www.marketbeat.com/logos/articles/med_20230711070604_massive-upside-forecasted-in-alta-equipment-group.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMFJLYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--6e6176218075a0b6793fa8b685dcf3bd9c8a1210/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230711070604_massive-upside-forecasted-in-alta-equipment-group.jpg?locale=de)
Massive Upside Forecasted In Alta Equipment Group
Only sometimes do investors get the opportunity to consider cyclically favorable sectors and, even harder still, to successfully pick a stock within the sector that is set to outperform its peers
![Is Samsung's Warning Of A Chip Glut Hurting DRAM Maker Micron?: https://www.marketbeat.com/logos/articles/med_20230710123921_is-samsungs-warning-of-a-chip-glut-hurting-dram-ma.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBL1ZKYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--7a78391fabe5b8b4789e3226b8222420ecc32b6f/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230710123921_is-samsungs-warning-of-a-chip-glut-hurting-dram-ma.jpg?locale=de)
Is Samsung's Warning Of A Chip Glut Hurting DRAM Maker Micron?
Remember the pandemic-era chip shortage? Well, that’s history now, and there’s currently a chip glut, according to Samsung Electronics Co., Ltd. (OTCMKTS: SSNLF), which warned that its profit
![Accolade: A Rising Personalized AI-Powered Healthcare Platform: https://www.marketbeat.com/logos/articles/med_20230709131618_chart-accd.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBL0pKYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--81a0aaf652672922732493576c882991a89eb45f/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230709131618_chart-accd.jpg?locale=de)
Accolade: A Rising Personalized AI-Powered Healthcare Platform
Accolade Inc. (NASDAQ: ACCD) is an artificial intelligence (AI) powered healthcare platform that provides personalized healthcare guidance for employers and workers. The platform helps people